These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26998088)

  • 1. NRAGE promotes the malignant phenotype of hepatocellular carcinoma.
    Shimizu D; Kanda M; Sugimoto H; Sueoka S; Takami H; Ezaka K; Tanaka Y; Hashimoto R; Okamura Y; Iwata N; Tanaka C; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Oncol Lett; 2016 Mar; 11(3):1847-1854. PubMed ID: 26998088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer.
    Kanda M; Shimizu D; Fujii T; Tanaka H; Tanaka Y; Ezaka K; Shibata M; Takami H; Hashimoto R; Sueoka S; Iwata N; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Aug; 23(Suppl 4):532-539. PubMed ID: 27364510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy.
    Hashimoto R; Kanda M; Takami H; Shimizu D; Oya H; Hibino S; Okamura Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Oncol Lett; 2015 Mar; 9(3):1201-1206. PubMed ID: 25663882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the ERK pathway.
    Zhang H; Wu G; Chen B
    Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.
    Yang Q; Ou C; Liu M; Xiao W; Wen C; Sun F
    Carcinogenesis; 2014 Jul; 35(7):1643-51. PubMed ID: 24710624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer.
    Jiang X; Jiang X; Yang Z
    Gene; 2018 Aug; 668():114-120. PubMed ID: 29778424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma.
    Tanaka Y; Kanda M; Sugimoto H; Shimizu D; Sueoka S; Takami H; Ezaka K; Hashimoto R; Okamura Y; Iwata N; Tanaka C; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Int J Oncol; 2015; 46(6):2546-54. PubMed ID: 25892360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma.
    Kumar DP; Santhekadur PK; Seneshaw M; Mirshahi F; Uram-Tuculescu C; Sanyal AJ
    Hepatology; 2019 Apr; 69(4):1520-1534. PubMed ID: 30394550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis.
    Yang Q; Pan Q; Li C; Xu Y; Wen C; Sun F
    Cell Death Differ; 2016 Aug; 23(8):1406-16. PubMed ID: 27035619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of a novel p75(NTR) signaling protein, which regulates cell cycle progression and apoptosis.
    Kendall SE; Goldhawk DE; Kubu C; Barker PA; Verdi JM
    Mech Dev; 2002 Sep; 117(1-2):187-200. PubMed ID: 12204258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of the P75 neurotrophin receptor and neurotrophin receptor-interacting melanoma antigen homolog in the mature rat brain.
    Barrett GL; Greferath U; Barker PA; Trieu J; Bennie A
    Neuroscience; 2005; 133(2):381-92. PubMed ID: 15878242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
    Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.
    Salehi AH; Roux PP; Kubu CJ; Zeindler C; Bhakar A; Tannis LL; Verdi JM; Barker PA
    Neuron; 2000 Aug; 27(2):279-88. PubMed ID: 10985348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.
    Kanda M; Sugimoto H; Nomoto S; Oya H; Shimizu D; Takami H; Hashimoto R; Sonohara F; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2014 Nov; 45(5):2005-12. PubMed ID: 25189544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death.
    Di Certo MG; Corbi N; Bruno T; Iezzi S; De Nicola F; Desantis A; Ciotti MT; Mattei E; Floridi A; Fanciulli M; Passananti C
    J Cell Sci; 2007 Jun; 120(Pt 11):1852-8. PubMed ID: 17488777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
    Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
    Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Neurotrophin Receptor-interacting MAGE Homolog on Apoptosis of Intestinal Epithelial Cells].
    Feng Q; Hu YL; Zou GJ; Zhang CJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):556-560. PubMed ID: 28752974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.